You have 9 free searches left this month | for more free features.

Elagolix E2/NETA (Elagolix Norethindrone acetate)

Showing 1 - 25 of 1,339

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))

Completed
  • Heavy Uterine Bleeding
  • Uterine Fibroids
  • (no location specified)
Jul 9, 2021

Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)

Completed
  • Heavy Uterine Bleeding
  • Uterine Fibroids
  • Elagolix placebo
  • +4 more
  • (no location specified)
Jul 7, 2020

Assess Patient-Reported Quality of Life and Effectiveness on

Recruiting
  • Heavy Menstrual Bleeding
  • Uterine Fibroids
    • Durham, North Carolina
      IQVIA RDS, Inc
    Nov 2, 2021

    Endometriosis Trial in Boston (norethindrone acetate (NETA), Placebo)

    Not yet recruiting
    • Endometriosis
    • norethindrone acetate (NETA)
    • Placebo
    • Boston, Massachusetts
      Boston Children's Hospital
    Sep 14, 2022

    Hair in Adult Participants Taking Oral Oriahnn Capsules With

    Not yet recruiting
    • Uterine Fibroids (UF)
      • (no location specified)
      Sep 22, 2023

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +104 more
      Jul 9, 2021

      Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)

      Active, not recruiting
      • Heavy Menstrual Bleeding
      • Uterine Fibroids
      • Elagolix Placebo
      • +3 more
      • Birmingham, Alabama
      • +156 more
      Jan 20, 2022

      Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)

      Active, not recruiting
      • Endometriosis
      • Estradiol/Norethindrone Acetate
      • +3 more
      • Birmingham, Alabama
      • +196 more
      Feb 14, 2022

      Elagolix For the Treatment of Endometriosis in Canada

      Completed
      • Endometriosis
        • Calgary, Alberta, Canada
        • +17 more
        Sep 26, 2022

        Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,

        Completed
        • Uterine Fibroids
        • Heavy Menstrual Bleeding
        • Birmingham, Alabama
        • +123 more
        Jul 9, 2021

        Healthy Trial in Hialeah (Relugolix/E2/NETA FDC, Relugolix, Erythromycin)

        Completed
        • Healthy
        • Relugolix/E2/NETA FDC
        • +2 more
        • Hialeah, Florida
          Clinical Pharmacology of Miami, An Evolution Research Group Port
        Aug 30, 2021

        Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Elagolix, Placebo for

        Completed
        • Uterine Fibroids
        • Heavy Menstrual Bleeding
        • Birmingham, Alabama
        • +95 more
        Jun 9, 2020

        Endometriosis Trial in United States (elagolix, estradiol/norethindrone acetate (E2/NETA))

        Terminated
        • Endometriosis
        • elagolix
        • estradiol/norethindrone acetate (E2/NETA)
        • Anniston, Alabama
        • +36 more
        Nov 8, 2019

        Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

        Active, not recruiting
        • Endometriosis
        • Andalusia, Alabama
        • +168 more
        May 31, 2022

        Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)

        Recruiting
        • Endometriosis
        • Unexplained Infertility
        • Winston-Salem, North Carolina
          Wake Forest Univesity Health Sciences
        Dec 1, 2022

        Heavy Menstrual Bleeding, Bleeding Disorder, Von Willebrand Diseases Trial (Levonorgestrel Intrauterine System, Norethindrone

        Not yet recruiting
        • Heavy Menstrual Bleeding
        • +2 more
        • Levonorgestrel Intrauterine System
        • Norethindrone Acetate
        • (no location specified)
        Jun 14, 2023

        Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for

        Active, not recruiting
        • Heavy Menstrual Bleeding
        • Fibroid Uterus
        • Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure
        • Elagolix Oral Product
        • Washington, District of Columbia
          MedStar Washington Hospital Center
        Apr 29, 2022

        Infertility, Endometriosis Trial in Lone Tree (Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work)

        Recruiting
        • Infertility
        • Endometriosis
        • Elagolix 200 MG
        • +2 more
        • Lone Tree, Colorado
          Colorado Center for Reproductive Medicine
        Jul 20, 2022

        Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)

        Completed
        • Polycystic Ovary Syndrome
        • Birmingham, Alabama
        • +53 more
        May 16, 2022

        Uterine Fibroids Trial in Puerto Rico, United States (Elagolix, Placebo)

        Completed
        • Uterine Fibroids
        • Birmingham, Alabama
        • +47 more
        Mar 4, 2022

        Heavy Menstrual Bleeding, Uterine Fibroid Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

        Completed
        • Heavy Menstrual Bleeding
        • Uterine Fibroid
        • Andalusia, Alabama
        • +149 more
        Jun 7, 2021

        Endometriosis Trial (Elagolix)

        Completed
        • Endometriosis
        • (no location specified)
        Jul 9, 2021

        Endometriosis Trial (Elagolix)

        Completed
        • Endometriosis
        • (no location specified)
        Jul 9, 2021